-
公开(公告)号:US20240150691A1
公开(公告)日:2024-05-09
申请号:US18280659
申请日:2022-03-09
Applicant: Kyoto University , OSAKA UNIVERSITY
Inventor: Kazuo TAKAYAMA , Yusuke TORISAWA , Kenji OSAFUNE , Maki KOTAKA , Sayaka DEGUCHI , Hiroyuki MIZUGUCHI
Abstract: There is provided a bile duct chip that is a bile duct chip (200) including a membrane (210) through which substances are movable from one surface to the other surface, a first substrate (221) having a recessed part that forms a first flow path (220), and a second substrate (231) having a recessed part that forms a second flow path (230), in which the first substrate (221), the membrane (210), the second substrate (231) are stacked in this order, the recessed part of the first substrate (221) has an opening portion facing the one surface of the membrane (210), the recessed part of the second substrate has an opening portion facing the other surface of the membrane (210), the one surface of the membrane (210) forms a part of the first flow path (220), the other surface of the membrane (210) forms a part of the second flow path (230), the first flow path (220) and the second flow path (230) communicate with each other through the membrane (210), and bile duct epithelial cells (222) are disposed on a surface of an inner wall of the first flow path (220) to form a tube.
-
公开(公告)号:US20240043811A1
公开(公告)日:2024-02-08
申请号:US18487457
申请日:2023-10-16
Applicant: KYOTO UNIVERSITY
Inventor: Shinichi SUETA , Tomoko KASAHARA , Kenji OSAFUNE
CPC classification number: C12N5/0687 , C12N5/0696 , C12N2501/115 , C12N2501/119 , C12N2501/155 , C12N2501/998 , C12N2533/52
Abstract: A method of producing a mesodermal-lineage primitive streak cell includes a first step of culturing pluripotent stem cells in a medium containing FGF2, BMP (bone morphogenetic protein) 4, a GSK-3β inhibitor, and retinoic acid or a derivative thereof and a second step of culturing cells obtained in the first step in a medium containing FGF2, a GSK-3β inhibitor, and BMP7.
-
3.
公开(公告)号:US20160068816A1
公开(公告)日:2016-03-10
申请号:US14783382
申请日:2014-04-14
Applicant: Kyoto University
Inventor: Kenji OSAFUNE , Shimpei GOTOH , Isao ITO , Michiaki MISHIMA
IPC: C12N5/071
CPC classification number: C12N5/0688 , C12N2500/38 , C12N2501/01 , C12N2501/065 , C12N2501/117 , C12N2501/119 , C12N2501/15 , C12N2501/155 , C12N2501/16 , C12N2501/385 , C12N2501/39 , C12N2501/415 , C12N2501/727 , C12N2501/73 , C12N2501/999 , C12N2506/45
Abstract: This invention provides a method for stably producing alveolar epithelial progenitor cells from pluripotent stem cells, including steps of culturing pluripotent stem cells in (1) a medium containing activin A and a GSK3β inhibitor, (2) a medium containing a BMP inhibitor and a TGFβ inhibitor, and (3) a medium containing BMP4, retinoic acid, and a GSK3β inhibitor.
Abstract translation: 本发明提供了一种从多能干细胞稳定产生肺泡上皮祖细胞的方法,包括在(1)含有激活素A和GSK3和bgr的培养基中培养多能干细胞的步骤; 抑制剂,(2)含有BMP抑制剂和TGFβb的培养基; 抑制剂,和(3)含有BMP4,视黄酸和GSK3&bgr的培养基; 抑制剂。
-
公开(公告)号:US20210009960A1
公开(公告)日:2021-01-14
申请号:US16763875
申请日:2018-11-16
Applicant: Kyoto University
Inventor: Kenji OSAFUNE , Shinichi MAE , Makoto RYOUSAKA
IPC: C12N5/071
Abstract: An object of the present application is to provide a method for inducing the differentiation from pluripotent stem cells, particularly iPS cells and ES cells, into ureteric bud cells. Another object of the present application is to provide a system for producing ureteric bud-like tissue from pluripotent stem cells through each stage of differentiations, i.e. anterior primitive streak cells, anterior intermediate mesoderm cells and Wolffian duct cells. Yet another object of the present application is to provide a method for maintaining ureteric bud-like organoids. Another object of the present application is to provide a method for expansion-culturing ureteric bud-like tip tissue.
-
公开(公告)号:US20180327719A1
公开(公告)日:2018-11-15
申请号:US15760523
申请日:2016-09-16
Applicant: Kyoto University
Inventor: Kenji OSAFUNE , Taro TOYODA , Azuma KIMURA
IPC: C12N5/071
CPC classification number: C12N5/0676 , C12N5/10 , C12N2501/11 , C12N2501/117 , C12N2501/155 , C12N2501/16 , C12N2501/41 , C12N2501/727 , C12N2506/03
Abstract: Provided is a method for generating pancreatic bud cells, comprising the step of culturing PDX1+/NKX6.1− cells in a medium comprising KGF, EGY, a DMP inhibitor and an Akt inhibitor. The cells may be cultured under adherent culture conditions. PDX1+/NKX6.1− cells may be induced from pluripotent stem cells in vitro. The method of this application makes it possible to generate pancreatic bud cells from pluripotent stem cells.
-
公开(公告)号:US20240318142A1
公开(公告)日:2024-09-26
申请号:US18682870
申请日:2022-08-10
Applicant: KYOTO UNIVERSITY , REGE NEPHRO CO., LTD.
Inventor: Kenji OSAFUNE , Hiraku TSUJIMOTO
IPC: C12N5/071
CPC classification number: C12N5/0687 , C12N2500/38 , C12N2501/115 , C12N2501/15 , C12N2501/155 , C12N2501/16 , C12N2501/2301 , C12N2501/41 , C12N2501/727 , C12N2506/45
Abstract: A method of producing renal interstitial progenitor cells, the method including the step of culturing HOXC10-positive cells in a medium comprising a GSK (glycogen synthase kinase)-3β inhibitor, a SHH (Sonic Hedgehog) signal activator, and a TGF (transforming growth factor) β inhibitor, and preferably also comprising IL (interleukin)-1β and retinoic acid, to induce the renal interstitial progenitor cells.
-
公开(公告)号:US20240010989A1
公开(公告)日:2024-01-11
申请号:US18271112
申请日:2022-01-11
Applicant: Kyoto University , Rege Nephro Co., Ltd.
Inventor: Kenji OSAFUNE , Toshikazu ARAOKA , Yoshifumi KOBAYASHI , Makoto RYOSAKA , Hiraku TSUJIMOTO
IPC: C12N5/071
CPC classification number: C12N5/0687 , C12N2506/45 , C12N2501/119 , C12N2501/115 , C12N2501/155 , C12N2501/15
Abstract: A medium for culturing and expanding nephron progenitor cells, the medium containing a GSK-3β inhibitor, a ROCK inhibitor, and at least one fibroblast growth factor selected from the group consisting of FGF9 and FGF20. Also, a method for culturing and expanding nephron progenitor cells using the medium. Also, a method for producing renal organoids, the method including a step of culturing and expanding nephron progenitor cells using the above method for culturing and expanding nephron progenitor cells, and a step of differentiating the cultured and expanded nephron progenitor cells into renal organoids.
-
公开(公告)号:US20240110157A1
公开(公告)日:2024-04-04
申请号:US18535328
申请日:2023-12-11
Applicant: KYOTO UNIVERSITY , Rege Nephro Co., Ltd. , NIKKISO CO., LTD.
Inventor: Kenji OSAFUNE , Shunjiro SUGIMOTO , Makoto RYOSAKA , Yoichi JIMBO , Fumihiko KITAGAWA
IPC: C12N5/071
CPC classification number: C12N5/0686 , C12N2523/00
Abstract: There are provided a cell aggregate that can be used as a cell preparation in regenerative medicine, maintains the original characteristics of cells, and has high safety, and a method for simply and safely maintaining the cell aggregate size, the cell characteristics and viability suitable for use as a cell preparation in regenerative medicine. According to an aspect of the present invention, a cell aggregate maintaining method is a method including a maintenance process of maintaining a liquid containing a plurality of the cell aggregates at a temperature which is lower than a culture temperature of the cells and at which the liquid is not frozen.
-
9.
公开(公告)号:US20210332329A1
公开(公告)日:2021-10-28
申请号:US17262398
申请日:2019-07-22
Applicant: KYOTO UNIVERSITY
Inventor: Kenji OSAFUNE , Toshikazu ARAOKA , Akira WATANABE
IPC: C12N5/071 , G01N33/569
Abstract: A method for concentrating renal progenitor cells involves extracting MET-positive cells and/or AGTR2-positive cells from a renal progenitor cell-containing cell population. The MET-positive cells and/or AGTR2-positive cells are extracted using an anti-MET antibody and/or an anti-AGTR2 antibody. The renal progenitor cell-containing cell population is obtained from pluripotent stem cells. The renal progenitor cells are OSR1 (odd-skipped related 1)-positive and SIX2 (SIX Homeobox 2)-positive.
-
公开(公告)号:US20210284968A1
公开(公告)日:2021-09-16
申请号:US17194761
申请日:2021-03-08
Applicant: KYOTO UNIVERSITY
Inventor: Kenji OSAFUNE , Shimpei GOTOH , Isao ITO , Michiaki MISHIMA
IPC: C12N5/071
Abstract: This invention provides a method for stably producing alveolar epithelial progenitor cells from pluripotent stem cells, including steps of culturing pluripotent stem cells in (1) a medium containing activin A and a GSK3β inhibitor, (2) a medium containing a BMP inhibitor and a TGFβ inhibitor, and (3) a medium containing BMP4, retinoic acid, and a GSK3β inhibitor.
-
-
-
-
-
-
-
-
-